Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Axel Finckh

Showing results (11-20 of 225) with videos related to

Pageof 23
Sort By:
Joint Bone Spine|March 31, 2020
Predictive factors of treatment persistence in rheumatoid arthritisKim Lauper, Axel Finckh
Current Opinion in Rheumatology|April 5, 2008
At the horizon of innovative therapy in rheumatology: new biologic agentsAxel Finckh, Cem Gabay
Swiss Medical Weekly|October 4, 2013
The importance of early treatment for the prognosis of rheumatoid arthritisDiego Kyburz, Axel Finckh
Revue Medicale Suisse|March 11, 2026
Axel Finckh, Thomas Hügle
Annals of the Rheumatic Diseases|November 12, 2020
Response to 'Correspondence on 'Impact of the COVID-19 pandemic on the disease course of patients with inflammatory rheumatic diseases: results from the Swiss Clinical Quality Management cohort' by Ruyssen-Witrand <i>et al</i>Adrian Ciurea, Axel Finckh
Annals of the Rheumatic Diseases|October 8, 2014
The impact of obesity on the development and progression of rheumatoid arthritisAxel Finckh, Carl Turesson
Nature Reviews. Rheumatology|November 2, 2010
Osteoarthritis: Small studies overestimate the benefit of therapies for OAAxel Finckh, Martin R Tramèr
The Journal of Rheumatology|December 3, 2019
Menopause and Possible Effect on Association Between Age and Anticyclic Citrullinated Peptide Antibodies in Women At Risk of Rheumatoid ArthritisDeshiré Alpizar-Rodriguez, Axel Finckh
Seminars in Immunopathology|April 29, 2017
Environmental factors and hormones in the development of rheumatoid arthritisDeshiré Alpízar-Rodríguez, Axel Finckh
Clinical Rheumatology|February 5, 2020
Is the prevention of rheumatoid arthritis possible?Deshiré Alpizar-Rodriguez, Axel Finckh
Pageof 23

Showing results (11-20 of 225) with videos related to

Sort By:
Pageof 23
Joint Bone Spine|March 31, 2020
Predictive factors of treatment persistence in rheumatoid arthritisKim Lauper, Axel Finckh
Current Opinion in Rheumatology|April 5, 2008
At the horizon of innovative therapy in rheumatology: new biologic agentsAxel Finckh, Cem Gabay
Swiss Medical Weekly|October 4, 2013
The importance of early treatment for the prognosis of rheumatoid arthritisDiego Kyburz, Axel Finckh
Revue Medicale Suisse|March 11, 2026
Axel Finckh, Thomas Hügle
Annals of the Rheumatic Diseases|November 12, 2020
Response to 'Correspondence on 'Impact of the COVID-19 pandemic on the disease course of patients with inflammatory rheumatic diseases: results from the Swiss Clinical Quality Management cohort' by Ruyssen-Witrand <i>et al</i>Adrian Ciurea, Axel Finckh
Annals of the Rheumatic Diseases|October 8, 2014
The impact of obesity on the development and progression of rheumatoid arthritisAxel Finckh, Carl Turesson
Nature Reviews. Rheumatology|November 2, 2010
Osteoarthritis: Small studies overestimate the benefit of therapies for OAAxel Finckh, Martin R Tramèr
The Journal of Rheumatology|December 3, 2019
Menopause and Possible Effect on Association Between Age and Anticyclic Citrullinated Peptide Antibodies in Women At Risk of Rheumatoid ArthritisDeshiré Alpizar-Rodriguez, Axel Finckh
Seminars in Immunopathology|April 29, 2017
Environmental factors and hormones in the development of rheumatoid arthritisDeshiré Alpízar-Rodríguez, Axel Finckh
Clinical Rheumatology|February 5, 2020
Is the prevention of rheumatoid arthritis possible?Deshiré Alpizar-Rodriguez, Axel Finckh
Pageof 23